It founds that there was significantly greater weight loss over a placebo among participants
Given the prevalence of cardiovascular disease, type 2 diabetes, chronic kidney disease, and metabolic syndrome, it seems plausible that GLP1s reduce all-cause mortality
The following risk considerations are precautionary in nature, reflecting general clinical principles rather than retatrutide-specific evidence
I just feel like something as simple as just getting down is a lot easier for me
Although this study only featured the data from one person taking tirzepatide, it provides compelling data about how GLP-1 and GIP inhibitors alter electrical signals in the brain, said study co-first author Wonkyung Choi, a PhD candidate at the University of Pennsylvania School of Medicine in Philadelphia
These stakeholders should assess their current practices and effectively transition during the brief window in which the FDA will employ enforcement discretion